Paratek Pharmaceuticals, Inc.
Paratek Pharmaceuticals, Inc.（PRTK）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PRTK · 截至 2026年6月9日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
30
近12个月
买卖比
0.17
Buy/Sell (by trades)
整体情绪
Paratek Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PRTK 季度内部人买卖趋势
PRTK 内幕交易卖出 · PRTK 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
PRTK 高管卖出股份 · PRTK 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Sep 21, 2023 | Baylor-Henry Minnie Director | Other | 32,800 | $71K | Form 4 |
| Sep 21, 2023 | Baylor-Henry Minnie Director | Other | 26,400 | — | Form 4 |
| Sep 21, 2023 | Hoffmann Rolf K Director | Other | 64,000 | $138K | Form 4 |
| Sep 21, 2023 | Hoffmann Rolf K Director | Other | 20,000 | — | Form 4 |
| Sep 21, 2023 | Brenner Randall B. Chief Development & Regulatory | Other | 329,709 | $709K | Form 4 |
| Sep 21, 2023 | Brenner Randall B. Chief Development & Regulatory | Other | 85,500 | — | Form 4 |
| Sep 21, 2023 | Peterson Kristine Director | Other | 59,000 | $127K | Form 4 |
| Sep 21, 2023 | Peterson Kristine Director | Other | 20,000 | — | Form 4 |
| Sep 21, 2023 | Stein Jeffrey Director | Other | 48,625 | $105K | Form 4 |
| Sep 21, 2023 | Stein Jeffrey Director | Other | 20,000 | — | Form 4 |
| Sep 21, 2023 | Haskel William M. CLO, General Counsel & Sec. | Other | 357,774 | $769K | Form 4 |
| Sep 21, 2023 | Haskel William M. CLO, General Counsel & Sec. | Other | 89,250 | — | Form 4 |
| Feb 2, 2018 | BIGHAM MICHAEL Exec. Chairman of the Board · Director | Option | 23,255 | $100K | Form 4 |
| Sep 21, 2023 | BIGHAM MICHAEL Exec. Chairman of the Board · Director | Other | 1,129,282 | $960K | Form 4 |
| Sep 21, 2023 | BIGHAM MICHAEL Exec. Chairman of the Board · Director | Other | 228,750 | — | Form 4 |
| Sep 21, 2023 | Franson Timothy R Director | Other | 52,000 | $112K | Form 4 |
| Sep 21, 2023 | Franson Timothy R Director | Other | 20,000 | — | Form 4 |
| Sep 21, 2023 | Woodrow Adam President & Chief Commercial | Other | 622,284 | $529K | Form 4 |
| Sep 21, 2023 | Woodrow Adam President & Chief Commercial | Other | 126,750 | — | Form 4 |
| Sep 21, 2023 | Loh Evan CEO · Director | Other | 1,069,231 | $2.30M⚡ | Form 4 |
| Sep 21, 2023 | Loh Evan CEO · Director | Other | 258,750 | — | Form 4 |
| Sep 21, 2023 | Dietz Thomas John Director | Other | 49,250 | $42K | Form 4 |
| Sep 21, 2023 | Dietz Thomas John Director | Other | 20,000 | — | Form 4 |
| Sep 21, 2023 | Radie Robert S Director | Other | 53,000 | $45K | Form 4 |
| Sep 21, 2023 | Radie Robert S Director | Other | 20,000 | — | Form 4 |
Brenner Randall B.
Chief Development & Regulatory
日期
Sep 21
股数
329,709
均价
$2.15
总金额
$709K
Haskel William M.
CLO, General Counsel & Sec.
日期
Sep 21
股数
357,774
均价
$2.15
总金额
$769K
BIGHAM MICHAEL
Exec. Chairman of the Board · Director
日期
Feb 2
股数
23,255
均价
$4.30
总金额
$100K
BIGHAM MICHAEL
Exec. Chairman of the Board · Director
日期
Sep 21
股数
1,129,282
均价
$0.85
总金额
$960K
BIGHAM MICHAEL
Exec. Chairman of the Board · Director
日期
Sep 21
股数
228,750
均价
—
总金额
—
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PRTK 内幕交易
PRTK 内幕交易
Paratek Pharmaceuticals, Inc.（PRTK）内幕交易数据来源于公司内部人（包括PRTK）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。PRTK内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Paratek Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PRTK 内幕交易 · 5个问题Paratek Pharmaceuticals, Inc.（PRTK）的内部人包括高管和董事，如PRTK等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026